ResMed, an American medical device company, has agreed to acquire MEDIFOX DAN, a German out-of-hospital software solutions provider, from Hg for a sum of nearly $1 billion.

MEDIFOX DAN caters to ambulatory care services, care homes, and therapists across Germany with software solutions like MD Outpatient and MD Inpatient. Its clinical, operational, and financial solutions are mission-critical for out-of-hospital care providers such as care documentation, administration, personnel planning, billing, and others.

Dr. Thorsten Schliebe and Christian Städtler — MEDIFOX DAN Co-Managing Directors said: “We believe that the partnership with ResMed is a unique opportunity to fulfill this promise through the strategic perspectives of an international player on an even larger scale in the future. From now on we are part of a global company that specializes in the digitization of the healthcare system.

“A major benefit of this deal is the wide range of possibilities for an incredibly agile combination of a wide variety of services, from which our customers will particularly benefit in their everyday care work. We look forward to taking this next development step together and continue to support our customers in their daily work with innovative software solutions and services in the best possible way.”

The German firm’s offerings are said to be similar to ResMed’s US SaaS brands —Brightree and MatrixCare.

MEDIFOX DAN’s acquisition builds on the existing business of ResMed in Germany as a provider of cloud-connected medical devices for patients having sleep apnea and other respiratory disorders.

The German firm has a workforce of more than 600. Post-acquisition, it is intended to be operated under its existing brand within the ResMed SaaS business.

Mick Farrell — ResMed CEO said: “With the acquisition of MEDIFOX DAN, a fast-growing and innovative German healthcare software leader, we will expand ResMed’s SaaS business portfolio outside our current base in the U.S. market and strengthen our position as the global leader in healthcare software solutions for lower-cost and lower-acuity care.

“We are excited to welcome the MEDIFOX DAN team to our global ResMed family: Our management cultures are highly aligned with a laser-focus on lowering costs, improving outcomes, and changing the course of chronic disease management. MEDIFOX DAN has a strong track record of innovation, fully aligned with our teams at Brightree, MatrixCare, and beyond.”

Subject to regulatory approvals, the deal is likely to be wrapped up by the end of Q2 of ResMed’s fiscal year 2023.

  Christian Städtler, Dr. Thorsten Schliebe, Germany, Hg, MEDIFOX DAN, Mick Farrell, ResMed